Related Experiment Video
Updated: Jan 5, 2026
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
11.5K
Polymyxin derivatives as broad-spectrum antibiotic agents
Ma Su1, Minghui Wang1, Yuzhu Hong2
1Department of Chemistry, University of South Florida, Tampa, FL 33620, USA. jianfengcai@usf.edu.
Chemical Communications (Cambridge, England)
|October 16, 2019
Summary
New polymyxin derivatives show broad-spectrum antimicrobial activity. The lead compound P1 rapidly disrupts bacterial membranes, inhibits biofilms, and demonstrates strong in vivo efficacy against MRSA infections.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Pharmacology
Background:
- Polymyxins are critical last-resort antibiotics.
- Emergence of antibiotic resistance necessitates new antimicrobial agents.
- Bacterial membrane disruption is a key antimicrobial mechanism.
Purpose of the Study:
- To develop novel polymyxin derivatives with broad-spectrum antimicrobial properties.
- To evaluate the efficacy of these derivatives against resistant bacterial strains and biofilms.
- To assess the in vivo therapeutic potential of the lead compound.
Main Methods:
- Synthesis and characterization of novel polymyxin derivatives.
- In vitro assessment of antimicrobial activity, including membrane disruption assays.
- Biofilm inhibition assays using bacterial cultures.
- In vivo efficacy studies in a mouse model of Staphylococcus aureus infection.
Main Results:
- Several polymyxin derivatives demonstrated broad-spectrum antimicrobial activity.
- The lead compound, P1, rapidly disrupted bacterial membranes without inducing resistance.
- P1 effectively inhibited biofilm formation by Escherichia coli.
- P1 exhibited significant in vivo therapeutic effects in a mouse model of MRSA-induced thigh infection.
Conclusions:
- Novel polymyxin derivatives offer a promising avenue for combating bacterial infections.
- The lead compound P1 possesses potent antimicrobial and anti-biofilm activities.
- P1 demonstrates excellent potential for treating challenging infections, including those caused by MRSA.
More Related Videos
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
633
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
633
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
152
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
152
01:30Development of Antibiotic Resistance
1.1K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
735
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
735
01:23Antimicrobial Proteins
12.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K